Literature DB >> 28529985

Recent trends of gastric cancer treatment in Turkey.

Ali Guner1.   

Abstract

Gastric cancer is the fifth most common type of cancer and is the fourth most common death due to cancer in Turkey. Incidence and mortality rates are one of the highest among European countries. Despite the high rates, management of gastric cancer is still an issue of debate in Turkey and national guidelines have yet to be established. While the treatment plan following the diagnosis of gastric cancer is determined by a multidisciplinary meeting at high-volume centers, the plan in the majority of cases in Turkey is decided based on the decision of an individual physician. The primary goal of the treatment strategy is to obtain the best oncological outcomes and quality of life within the acceptable treatment-related morbidity. Therefore, R0 resection is intended by using standardized surgery with an individualized approach, while avoiding surgery if a curative resection is not possible. In this review, presenting on the recent trends of gastric cancer treatment including surgical, endoscopic, adjuvant/neoadjuvant and conversion treatment options in Turkey are aimed by exploring the institutional approach.

Entities:  

Keywords:  Gastric cancer; Turkey; surgery; treatment

Year:  2017        PMID: 28529985      PMCID: PMC5420516          DOI: 10.21037/tgh.2017.04.01

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN: 2415-1289


  31 in total

1.  Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.

Authors:  K Inoue; Y Nakane; M Kogire; K Fujitani; Y Kimura; H Imamura; S Tamura; S Okano; A H Kwon; Y Kurokawa; T Shimokawa; H Takiuchi; T Tsujinaka; H Furukawa
Journal:  Eur J Surg Oncol       Date:  2011-12-09       Impact factor: 4.424

2.  Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer (Br J Surg 2014; 101: 23-31).

Authors:  C J H van de Velde
Journal:  Br J Surg       Date:  2014-01       Impact factor: 6.939

3.  Endoscopic submucosal dissection in gastric lesions: the 100 cases experience from a tertiary reference center in West.

Authors:  Fatih Aslan; Emrah Alper; Cem Cekıc; Derya Arslan Yurtlu; Nese Ekıncı; Mahmut Arabul; Belkis Unsal; Yoshimasa Mıura; Hironori Yamamoto
Journal:  Scand J Gastroenterol       Date:  2015-01-13       Impact factor: 2.423

4.  Survival benefit of bursectomy in patients with resectable gastric cancer: interim analysis results of a randomized controlled trial.

Authors:  Junya Fujita; Yukinori Kurokawa; Tomoyuki Sugimoto; Isao Miyashiro; Shohei Iijima; Yutaka Kimura; Shuji Takiguchi; Yoshiyuki Fujiwara; Masaki Mori; Yuichiro Doki
Journal:  Gastric Cancer       Date:  2011-05-15       Impact factor: 7.370

5.  Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.

Authors:  A Cuschieri; P Fayers; J Fielding; J Craven; J Bancewicz; V Joypaul; P Cook
Journal:  Lancet       Date:  1996-04-13       Impact factor: 79.321

6.  Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses.

Authors:  Se Hoon Park; Tae Sung Sohn; Jeeyun Lee; Do Hoon Lim; Min Eui Hong; Kyoung-Mee Kim; Insuk Sohn; Sin Ho Jung; Min Gew Choi; Jun Ho Lee; Jae Moon Bae; Sung Kim; Seung Tae Kim; Joon Oh Park; Young Suk Park; Ho Yeong Lim; Won Ki Kang
Journal:  J Clin Oncol       Date:  2015-01-05       Impact factor: 44.544

7.  Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Jaffer A Ajani; Thomas A D'Amico; Khaldoun Almhanna; David J Bentrem; Joseph Chao; Prajnan Das; Crystal S Denlinger; Paul Fanta; Farhood Farjah; Charles S Fuchs; Hans Gerdes; Michael Gibson; Robert E Glasgow; James A Hayman; Steven Hochwald; Wayne L Hofstetter; David H Ilson; Dawn Jaroszewski; Kimberly L Johung; Rajesh N Keswani; Lawrence R Kleinberg; W Michael Korn; Stephen Leong; Catherine Linn; A Craig Lockhart; Quan P Ly; Mary F Mulcahy; Mark B Orringer; Kyle A Perry; George A Poultsides; Walter J Scott; Vivian E Strong; Mary Kay Washington; Benny Weksler; Christopher G Willett; Cameron D Wright; Debra Zelman; Nicole McMillian; Hema Sundar
Journal:  J Natl Compr Canc Netw       Date:  2016-10       Impact factor: 11.908

8.  End-of-study results of Turkish gastric cancer patients from the global REGATE study.

Authors:  Suayib Yalcin; Mahmut Gumus; Saadettin Kilickap; Necati Alkis; Mahmut Ilhan; Berna Oksuzoglu; Bulent Orhan; Mustafa Unsal; Salim Basol Tekin; Bulent Yalcin; Gokhan Demir
Journal:  J BUON       Date:  2014 Apr-Jun       Impact factor: 2.533

9.  Predictive Potential of Preoperative Nutritional Status in Long-Term Outcome Projections for Patients with Gastric Cancer.

Authors:  Katsunobu Sakurai; Masaichi Ohira; Tatsuro Tamura; Takahiro Toyokawa; Ryosuke Amano; Naoshi Kubo; Hiroaki Tanaka; Kazuya Muguruma; Masakazu Yashiro; Kiyoshi Maeda; Kosei Hirakawa
Journal:  Ann Surg Oncol       Date:  2015-08-26       Impact factor: 5.344

10.  Japanese gastric cancer treatment guidelines 2014 (ver. 4).

Authors: 
Journal:  Gastric Cancer       Date:  2016-06-24       Impact factor: 7.370

View more
  2 in total

Review 1.  Dealing with the gray zones in the management of gastric cancer: The consensus statement of the İstanbul Group.

Authors:  Erman Aytaç; Fatih Aslan; Bahattin Çicek; Sibel Erdamar; Bengi Gürses; Koray Güven; Okan Falay; Tayfun Karahasanoğlu; Fatih Selçukbiricik; Uğur Selek; Banu Atalar; Emre Balık; Nurdan Tözün; İzzet Rozanes; Ali Arıcan; İsmail Hamzaoğlu; Bilgi Baca; Nil Molinas Mandel; Murat Saruç; Süha Göksel; Gökhan Demir; Fulya Ağaoğlu; Cengiz Yakıcıer; Uğur Özbek; Volkan Özben; Enis Özyar; Ahmet Levent Güner; Özlem Er; Kerim Kaban; Yasemin Bölükbaşı; Dursun Buğra; The İstanbul Group
Journal:  Turk J Gastroenterol       Date:  2019-07       Impact factor: 1.852

2.  The efficacy of clinical pathway in gastric cancer surgery.

Authors:  Ali Güner
Journal:  Turk J Surg       Date:  2020-03-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.